Fc receptor-antibody interactions are key mechanisms through which antibody
effector functions are mediated. Neutrophils coexpress two low-affinity Fc
gamma receptors, CD16b (Fc gamma RIIIb) and CD32a (Fc gamma RIIa), possess
ing overlapping ligand binding specificities but distinct membrane anchor a
nd signaling capacities. Using K562 cell transfectants as a model, the kine
tics of both separate and concurrent binding of CD16b and CD32a to surface-
bound IgG ligands were studied. CD16b bound human IgG with 2-3 times higher
affinity than did CD32a (A(c)K(a) = 4.1 and 1.6 x 10(-7) mu m(4), respecti
vely) and both Fc gamma Rs had similar reverse kinetic rates (k(r) = 0.5 an
d 0.4 s(-1), respectively). Because CD16b is expressed on neutrophils at a
4-5 times higher density than CD32a, our results suggest that CD16b plays t
he dominant role in binding of neutrophils to immobilized IgG. The question
of possible cross-regulation of binding affinity between CD16b and CD32a w
as investigated using our multispecies concurrent binding model (Zhu and Wi
lliams, Biophys. J. 79:1850-1857, 2000). Because the model assumes independ
ent binding (no cooperation among different species), the excellent agreeme
nt between the model predictions and the experimental data suggests that, w
hen coexpressed on K562 cells, these two Fc gamma Rs do not interact in a m
anner that alters the kinetic rates of either molecule.